Toll Free: 1-888-928-9744

United States PDE Inhibitors Industry 2017 Market Research Report

Published: Feb, 2017 | Pages: 120 | Publisher: QYResearch
Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)

Notes:
Sales, means the sales volume of PDE Inhibitors
Revenue, means the sales value of PDE Inhibitors

This report studies sales (consumption) of PDE Inhibitors in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering
    Hanmi Science Holding
    Boehringer Ingelheim
    Takeda Pharmaceuticals
    Pfizer
    Omeros Corporation
    Anacor Pharmaceuticals
    Otsuka
    Chiesi Farmaceutici
    Verona Pharma
    NuSirt Biopharma

Market Segment by States, covering
    California
    Texas
    New York
    Florida
    Illinois
Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into
    PDE5
    PDE4
    Viagra?
    Cialis?
    Levitra
    Others
Split by applications, this report focuses on sales, market share and growth rate of  PDE Inhibitors in each application, can be divided into
    GENITOURINARY
    CARDIOVASCULAR DISEASES
    NEUROLOGICAL DISEASES
    DERMATOLOGICAL DISORDERS
    RESPIRATORY DISEASES
    OTHER INDICATIONS

 Table of Contents

United States PDE Inhibitors Market Report 2017
1 PDE Inhibitors Overview
    1.1 Product Overview and Scope of PDE Inhibitors
    1.2 Classification of PDE Inhibitors
        1.2.1 PDE5
        1.2.2 PDE4
        1.2.3 Viagra?
        1.2.4 Cialis?
        1.2.5 Levitra
        1.2.6 Others
    1.3 Application of PDE Inhibitors
        1.3.1 GENITOURINARY
        1.3.2 CARDIOVASCULAR DISEASES
        1.3.3 NEUROLOGICAL DISEASES
        1.3.4 DERMATOLOGICAL DISORDERS
        1.3.5 RESPIRATORY DISEASES
        1.3.6 OTHER INDICATIONS
    1.4 United States Market Size Sales (Volume) and Revenue (Value) of PDE Inhibitors (2012-2022)
        1.4.1 United States PDE Inhibitors Sales and Growth Rate (2012-2022)
        1.4.2 United States PDE Inhibitors Revenue and Growth Rate (2012-2022)

2 United States PDE Inhibitors Competition by Manufacturers
    2.1 United States PDE Inhibitors Sales and Market Share of Key Manufacturers (2015 and 2016)
    2.2 United States PDE Inhibitors Revenue and Share by Manufactures (2015 and 2016)
    2.3 United States PDE Inhibitors Average Price by Manufactures (2015 and 2016)
    2.4 PDE Inhibitors Market Competitive Situation and Trends
        2.4.1 PDE Inhibitors Market Concentration Rate
        2.4.2 PDE Inhibitors Market Share of Top 3 and Top 5 Manufacturers
        2.4.3 Mergers & Acquisitions, Expansion

3 United States PDE Inhibitors Sales (Volume) and Revenue (Value) by States (2012-2017)
    3.1 United States PDE Inhibitors Sales and Market Share by States (2012-2017)
    3.2 United States PDE Inhibitors Revenue and Market Share by States (2012-2017)
    3.3 United States PDE Inhibitors Price by States (2012-2017)

4 United States PDE Inhibitors Sales (Volume) and Revenue (Value) by Type (2012-2017)
    4.1 United States PDE Inhibitors Sales and Market Share by Type (2012-2017)
    4.2 United States PDE Inhibitors Revenue and Market Share by Type (2012-2017)
    4.3 United States PDE Inhibitors Price by Type (2012-2017)
    4.4 United States PDE Inhibitors Sales Growth Rate by Type (2012-2017)

5 United States PDE Inhibitors Sales (Volume) by Application (2012-2017)
    5.1 United States PDE Inhibitors Sales and Market Share by Application (2012-2017)
    5.2 United States PDE Inhibitors Sales Growth Rate by Application (2012-2017)
    5.3 Market Drivers and Opportunities

6 United States PDE Inhibitors Manufacturers Profiles/Analysis
    6.1 Hanmi Science Holding
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 PDE Inhibitors Product Type, Application and Specification
            6.1.2.1 PDE5
            6.1.2.2 PDE4
        6.1.3 Hanmi Science Holding PDE Inhibitors Sales, Revenue, Price and Gross Margin (2012-2017)
        6.1.4 Main Business/Business Overview
    6.2 Boehringer Ingelheim
        6.2.2 PDE Inhibitors Product Type, Application and Specification
            6.2.2.1 PDE5
            6.2.2.2 PDE4
        6.2.3 Boehringer Ingelheim PDE Inhibitors Sales, Revenue, Price and Gross Margin (2012-2017)
        6.2.4 Main Business/Business Overview
    6.3 Takeda Pharmaceuticals
        6.3.2 PDE Inhibitors Product Type, Application and Specification
            6.3.2.1 PDE5
            6.3.2.2 PDE4
        6.3.3 Takeda Pharmaceuticals PDE Inhibitors Sales, Revenue, Price and Gross Margin (2012-2017)
        6.3.4 Main Business/Business Overview
    6.4 Pfizer
        6.4.2 PDE Inhibitors Product Type, Application and Specification
            6.4.2.1 PDE5
            6.4.2.2 PDE4
        6.4.3 Pfizer PDE Inhibitors Sales, Revenue, Price and Gross Margin (2012-2017)
        6.4.4 Main Business/Business Overview
    6.5 Omeros Corporation
        6.5.2 PDE Inhibitors Product Type, Application and Specification
            6.5.2.1 PDE5
            6.5.2.2 PDE4
        6.5.3 Omeros Corporation PDE Inhibitors Sales, Revenue, Price and Gross Margin (2012-2017)
        6.5.4 Main Business/Business Overview
    6.6 Anacor Pharmaceuticals
        6.6.2 PDE Inhibitors Product Type, Application and Specification
            6.6.2.1 PDE5
            6.6.2.2 PDE4
        6.6.3 Anacor Pharmaceuticals PDE Inhibitors Sales, Revenue, Price and Gross Margin (2012-2017)
        6.6.4 Main Business/Business Overview
    6.7 Otsuka
        6.7.2 PDE Inhibitors Product Type, Application and Specification
            6.7.2.1 PDE5
            6.7.2.2 PDE4
        6.7.3 Otsuka PDE Inhibitors Sales, Revenue, Price and Gross Margin (2012-2017)
        6.7.4 Main Business/Business Overview
    6.8 Chiesi Farmaceutici
        6.8.2 PDE Inhibitors Product Type, Application and Specification
            6.8.2.1 PDE5
            6.8.2.2 PDE4
        6.8.3 Chiesi Farmaceutici PDE Inhibitors Sales, Revenue, Price and Gross Margin (2012-2017)
        6.8.4 Main Business/Business Overview
    6.9 Verona Pharma
        6.9.2 PDE Inhibitors Product Type, Application and Specification
            6.9.2.1 PDE5
            6.9.2.2 PDE4
        6.9.3 Verona Pharma PDE Inhibitors Sales, Revenue, Price and Gross Margin (2012-2017)
        6.9.4 Main Business/Business Overview
    6.10 NuSirt Biopharma
        6.10.2 PDE Inhibitors Product Type, Application and Specification
            6.10.2.1 PDE5
            6.10.2.2 PDE4
        6.10.3 NuSirt Biopharma PDE Inhibitors Sales, Revenue, Price and Gross Margin (2012-2017)
        6.10.4 Main Business/Business Overview

7 PDE Inhibitors Manufacturing Cost Analysis
    7.1 PDE Inhibitors Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of PDE Inhibitors

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 PDE Inhibitors Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of PDE Inhibitors Major Manufacturers in 2015
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 United States PDE Inhibitors Market Forecast (2017-2022)
    11.1 United States PDE Inhibitors Sales, Revenue Forecast (2017-2022)
    11.2 United States PDE Inhibitors Sales Forecast by Type (2017-2022)
    11.3 United States PDE Inhibitors Sales Forecast by Application (2017-2022)
    11.4 PDE Inhibitors Price Forecast (2017-2022)

12 Research Findings and Conclusion

13 Appendix
    Methodology
    Analyst Introduction
    Data Source

List of Tables and Figures 

    Figure Picture of PDE Inhibitors
    Table Classification of PDE Inhibitors
    Figure United States Sales Market Share of PDE Inhibitors by Type in 2015
    Figure PDE5 Picture
    Figure PDE4 Picture
    Figure Viagra? Picture
    Figure Cialis? Picture
    Figure Levitra Picture
    Figure Others Picture
    Table Application of PDE Inhibitors
    Figure United States Sales Market Share of PDE Inhibitors by Application in 2015
    Figure GENITOURINARY Examples
    Figure CARDIOVASCULAR DISEASES Examples
    Figure NEUROLOGICAL DISEASES Examples
    Figure DERMATOLOGICAL DISORDERS Examples
    Figure RESPIRATORY DISEASES Examples
    Figure OTHER INDICATIONS Examples
    Figure United States PDE Inhibitors Sales and Growth Rate (2012-2022)
    Figure United States PDE Inhibitors Revenue and Growth Rate (2012-2022)
    Table United States PDE Inhibitors Sales of Key Manufacturers (2015 and 2016)
    Table United States PDE Inhibitors Sales Share by Manufacturers (2015 and 2016)
    Figure 2015 PDE Inhibitors Sales Share by Manufacturers
    Figure 2016 PDE Inhibitors Sales Share by Manufacturers
    Table United States PDE Inhibitors Revenue by Manufacturers (2015 and 2016)
    Table United States PDE Inhibitors Revenue Share by Manufacturers (2015 and 2016)
    Table 2015 United States PDE Inhibitors Revenue Share by Manufacturers
    Table 2016 United States PDE Inhibitors Revenue Share by Manufacturers
    Table United States Market PDE Inhibitors Average Price of Key Manufacturers (2015 and 2016)
    Figure United States Market PDE Inhibitors Average Price of Key Manufacturers in 2015
    Figure PDE Inhibitors Market Share of Top 3 Manufacturers
    Figure PDE Inhibitors Market Share of Top 5 Manufacturers
    Table United States PDE Inhibitors Sales by States (2012-2017)
    Table United States PDE Inhibitors Sales Share by States (2012-2017)
    Figure United States PDE Inhibitors Sales Market Share by States in 2015
    Table United States PDE Inhibitors Revenue and Market Share by States (2012-2017)
    Table United States PDE Inhibitors Revenue Share by States (2012-2017)
    Figure Revenue Market Share of PDE Inhibitors by States (2012-2017)
    Table United States PDE Inhibitors Price by States (2012-2017)
    Table United States PDE Inhibitors Sales by Type (2012-2017)
    Table United States PDE Inhibitors Sales Share by Type (2012-2017)
    Figure United States PDE Inhibitors Sales Market Share by Type in 2015
    Table United States PDE Inhibitors Revenue and Market Share by Type (2012-2017)
    Table United States PDE Inhibitors Revenue Share by Type (2012-2017)
    Figure Revenue Market Share of PDE Inhibitors by Type (2012-2017)
    Table United States PDE Inhibitors Price by Type (2012-2017)
    Figure United States PDE Inhibitors Sales Growth Rate by Type (2012-2017)
    Table United States PDE Inhibitors Sales by Application (2012-2017)
    Table United States PDE Inhibitors Sales Market Share by Application (2012-2017)
    Figure United States PDE Inhibitors Sales Market Share by Application in 2015
    Table United States PDE Inhibitors Sales Growth Rate by Application (2012-2017)
    Figure United States PDE Inhibitors Sales Growth Rate by Application (2012-2017)
    Table Hanmi Science Holding Basic Information List
    Table Hanmi Science Holding PDE Inhibitors Sales, Revenue, Price and Gross Margin (2012-2017)
    Figure Hanmi Science Holding PDE Inhibitors Sales Market Share (2012-2017)
    Table Boehringer Ingelheim Basic Information List
    Table Boehringer Ingelheim PDE Inhibitors Sales, Revenue, Price and Gross Margin (2012-2017)
    Table Boehringer Ingelheim PDE Inhibitors Sales Market Share (2012-2017)
    Table Takeda Pharmaceuticals Basic Information List
    Table Takeda Pharmaceuticals PDE Inhibitors Sales, Revenue, Price and Gross Margin (2012-2017)
    Table Takeda Pharmaceuticals PDE Inhibitors Sales Market Share (2012-2017)
    Table Pfizer Basic Information List
    Table Pfizer PDE Inhibitors Sales, Revenue, Price and Gross Margin (2012-2017)
    Table Pfizer PDE Inhibitors Sales Market Share (2012-2017)
    Table Omeros Corporation Basic Information List
    Table Omeros Corporation PDE Inhibitors Sales, Revenue, Price and Gross Margin (2012-2017)
    Table Omeros Corporation PDE Inhibitors Sales Market Share (2012-2017)
    Table Anacor Pharmaceuticals Basic Information List
    Table Anacor Pharmaceuticals PDE Inhibitors Sales, Revenue, Price and Gross Margin (2012-2017)
    Table Anacor Pharmaceuticals PDE Inhibitors Sales Market Share (2012-2017)
    Table Otsuka Basic Information List
    Table Otsuka PDE Inhibitors Sales, Revenue, Price and Gross Margin (2012-2017)
    Table Otsuka PDE Inhibitors Sales Market Share (2012-2017)
    Table Chiesi Farmaceutici Basic Information List
    Table Chiesi Farmaceutici PDE Inhibitors Sales, Revenue, Price and Gross Margin (2012-2017)
    Table Chiesi Farmaceutici PDE Inhibitors Sales Market Share (2012-2017)
    Table Verona Pharma Basic Information List
    Table Verona Pharma PDE Inhibitors Sales, Revenue, Price and Gross Margin (2012-2017)
    Table Verona Pharma PDE Inhibitors Sales Market Share (2012-2017)
    Table NuSirt Biopharma Basic Information List
    Table NuSirt Biopharma PDE Inhibitors Sales, Revenue, Price and Gross Margin (2012-2017)
    Table NuSirt Biopharma PDE Inhibitors Sales Market Share (2012-2017)
    Table Production Base and Market Concentration Rate of Raw Material
    Figure Price Trend of Key Raw Materials
    Table Key Suppliers of Raw Materials
    Figure Manufacturing Cost Structure of PDE Inhibitors
    Figure Manufacturing Process Analysis of PDE Inhibitors
    Figure PDE Inhibitors Industrial Chain Analysis
    Table Raw Materials Sources of PDE Inhibitors Major Manufacturers in 2015
    Table Major Buyers of PDE Inhibitors
    Table Distributors/Traders List
    Figure United States PDE Inhibitors Production and Growth Rate Forecast (2017-2022)
    Figure United States PDE Inhibitors Revenue and Growth Rate Forecast (2017-2022)
    Table United States PDE Inhibitors Production Forecast by Type (2017-2022)
    Table United States PDE Inhibitors Consumption Forecast by Application (2017-2022)
    Table United States PDE Inhibitors Sales Forecast by States (2017-2022)
    Table United States PDE Inhibitors Sales Share Forecast by States (2017-2022)

 



To request a free sample copy of this report, please complete the form below.

We never share your personal data. Privacy policy
Interested in this report? Get your FREE sample now! Get a Free Sample
Choose License Type
Single User - US $3800
Multi User - US $7600
Hexareeasearch Know

Did you know?

Research Assistance

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Why to buy from us

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Information security

Your personal and confidential information is safe and secure.

verify